NCT07004868View on ClinicalTrials.gov

Inflammation, Cachexia and Therapeutic Response in Lung Cancer Treated With Immune Checkpoint Inhibitors: Exploratory Observational Study

RecruitingOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

June 3, 2025

Primary Completion Date

June 30, 2030

Study Completion Date

June 30, 2030

Conditions

Lung Cancer (NSCLC)

Trial Locations (1)

37000

RECRUITING

university hospital, Tours, Tours

All Listed Sponsors

lead

University Hospital, Tours

OTHER